Form 4: Sight Sciences Director Transfers Shares to Trust

Catherine Mazzacco, a Director at Sight Sciences, Inc., transferred 37,492 shares of common stock to an irrevocable trust for no consideration.

Summary

• Catherine Mazzacco, a Director of Sight Sciences, Inc. (SGHT), reported a transaction on September 11, 2025.
• She transferred 37,492 shares of Sight Sciences Common Stock to the Catherine Mazzacco Irrevocable Trust DTD 10/23/2023.
• The transfer was made for no consideration.
• Following this transaction, Catherine Mazzacco directly beneficially owns 41,015 shares of Common Stock.
• The transferred shares are now indirectly beneficially owned by her through the Trust, of which she is a beneficiary.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving a director's personal estate planning, which is neutral in terms of company performance or outlook.

Industry Context

This transaction is a personal estate planning move by a director and does not directly reflect broader industry trends or competitive dynamics.

Related Party Transactions

• Catherine Mazzacco transferred 37,492 shares of common stock to the Catherine Mazzacco Irrevocable Trust DTD 10/23/2023, of which she is a beneficiary, for no consideration.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a personal estate planning transaction by a director.

Key Dates

Keywords

Sight Sciences, SGHT, Form 4, Insider Transaction, Share Transfer, Catherine Mazzacco, Trust